|
Volumn 25, Issue 9, 2001, Pages 813-820
|
Pyridinyl imidazole inhibitor SB203580 activates p44/42 mitogen-activated protein kinase and induces the differentiation of human myeloid leukemia cells
|
Author keywords
Differentiation; Erk2; Kinase inhibitor; Leukemia cells; Mitogen activated protein kinase; P38 kinase; SB203580
|
Indexed keywords
4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE;
LYSOZYME;
MITOGEN ACTIVATED PROTEIN KINASE;
NITROBLUE TETRAZOLIUM;
SYNAPTOPHYSIN;
ARTICLE;
CELL DIFFERENTIATION;
CELL STRUCTURE;
CONTROLLED STUDY;
DRUG MECHANISM;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
ENZYME INHIBITION;
GROWTH INHIBITION;
HUMAN;
HUMAN CELL;
LEUKEMIA CELL;
LEUKEMIA CELL LINE;
MYELOID LEUKEMIA;
PRIORITY JOURNAL;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
CELL DIFFERENTIATION;
CELL DIVISION;
ENZYME ACTIVATION;
HL-60 CELLS;
HUMANS;
IMIDAZOLES;
LEUKEMIA, MYELOID;
MITOGEN-ACTIVATED PROTEIN KINASE 1;
MITOGEN-ACTIVATED PROTEIN KINASE 3;
MITOGEN-ACTIVATED PROTEIN KINASES;
P38 MITOGEN-ACTIVATED PROTEIN KINASES;
PYRIDINES;
TUMOR CELLS, CULTURED;
|
EID: 0034905018
PISSN: 01452126
EISSN: None
Source Type: Journal
DOI: 10.1016/S0145-2126(01)00026-1 Document Type: Article |
Times cited : (29)
|
References (31)
|